Yifei Wang

机构：Dalian Medical University · ORCID：0000-0002-2073-2837

发表论文 35 篇 · 总被引 623 次 · h-index 16

代表论文

• Irbesartan overcomes gemcitabine resistance in pancreatic cancer by suppressing stemness and iron metabolism via inhibition of the Hippo/YAP1/c-Jun axis (2023 · Journal of Experimental & Clinical Cancer Research · 被引 80)
• NEK2 promotes hepatocellular carcinoma migration and invasion through modulation of the epithelial-mesenchymal transition (2018 · Oncology Reports · 被引 59)
• SUFU suppresses ferroptosis sensitivity in breast cancer cells via Hippo/YAP pathway (2022 · iScience · 被引 47)
• Cancer‐associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2 – IGF1R and Hippo–YAP1 signaling pathways (2022 · The Journal of Pathology · 被引 45)
• SDCBP promotes pancreatic cancer progression by preventing YAP1 from β-TrCP-mediated proteasomal degradation (2023 · Gut · 被引 44)
• MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target (2022 · Theranostics · 被引 44)